OculoMax

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	17-02-2026	164 d early	2026-00041443
31-12-2024	31-07-2025	11-06-2025	50 d early	2025-00131327
31-12-2023	31-07-2024	10-06-2024	51 d early	2024-00118551

Metric	This company	Sector median	Position in the sector
Solvency	84.3%	58.1%	better than 78% of 2210 sector peers
Net result	€217k	€60k	better than 92% of 2208 sector peers
Equity	€393k	€74k	better than 92% of 2210 sector peers
Gross operating margin	€282k	€96k	better than 89% of 2210 sector peers
Total assets	€467k	€186k	better than 83% of 2210 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€467k
Formation expenses	20	€0
Current assets	29/58	€467k
Amounts receivable within one year	40/41	€76k
Cash & bank	54/58	€386k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€467k
Equity	10/15	€393k
Contributions / capital	10/11	€2k
Reserves	13	€391k
Amounts payable	17/49	€73k
Amounts payable within one year	42/48	€73k
Trade debts payable within one year	44	€344
Income statement
Gross operating margin	9900	€282k
Operating result	9901	€282k
Financial income	75	€2k
Financial charges	65	€47
Result before taxes	9903	€284k
Income taxes	67/77	€67k
Net result for the period	9904	€217k
Result to be appropriated	9905	€217k

Summary